Helmchen H
Psychiatrische Klinik, Freie Universität Berlin.
Nervenarzt. 2003 Nov;74(11):955-64. doi: 10.1007/s00115-003-1620-4.
Relationships between psychiatrists and the pharmaceutical industry have increased in frequency and intensity, both on the individual level and particularly on the institutional level. They extend from necessary and desirable cooperation to questionable practices and to unacceptable misconduct. Especially the latter has provoked a lively discussion and has initiated recommendations as well as guidelines. Their aim is to safeguard the integrity of physicians as well as the industry and to avoid endangering the relationship between the physician and the patient. They will do this by establishing clear norms, unequivocal documentation, and disclosure of relevant relationships in order to build up more mutual trust including that of the public. Based on a detailed review of the literature, 27 recommendations are put forward for discussion. Psychiatric associations should develop explicit guidelines for the relationships between psychiatrists and the pharmaceutical industry.
精神科医生与制药行业之间的关系在频率和强度上都有所增加，无论是在个人层面，尤其是在机构层面。这些关系涵盖了从必要且有益的合作到有问题的行为以及不可接受的不当行为。特别是后者引发了热烈的讨论，并催生了相关建议和指导方针。其目的是维护医生以及制药行业的诚信，并避免危及医患关系。他们将通过建立明确的规范、清晰的记录以及披露相关关系来实现这一目标，以便建立更多的相互信任，包括公众的信任。在对文献进行详细综述的基础上，提出了27条建议供讨论。精神科协会应为精神科医生与制药行业之间的关系制定明确的指导方针。
